CN Patent

CN101152154A — 盐酸决奈达隆口服药物组合物及其制备方法

Assigned to Beijing Wanquan Dezhong Medical Biological Technology Co Ltd · Expires 2008-04-02 · 18y expired

What this patent protects

本发明提供了一种固体药物组合物，其中含有微粒化的盐酸决奈达隆、表面活性剂和作为助溶剂的亲水性聚合物。主要用于治疗心律失常。

USPTO Abstract

本发明提供了一种固体药物组合物，其中含有微粒化的盐酸决奈达隆、表面活性剂和作为助溶剂的亲水性聚合物。主要用于治疗心律失常。

Drugs covered by this patent

Patent Metadata

Patent number
CN101152154A
Jurisdiction
CN
Classification
—
Expires
2008-04-02
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Wanquan Dezhong Medical Biological Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.